Clinical and Immunologic Characteristics of Non-Hematologic Cancers in Patients with Inborn Errors of Immunity

Inborn errors of immunity (IEI) are a heterogeneous group of inherited disorders, and almost 500 genes associated with these disorders have been identified. Defects in IEI genes lead to diverse clinical manifestations including increased susceptibility to recurrent or prolonged infections, immune dy...

Full description

Bibliographic Details
Main Authors: Samaneh Delavari, Yating Wang, Tannaz Moeini shad, Salar Pashangzadeh, Farzad Nazari, Fereshte Salami, Hassan Abolhassani
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/3/764
_version_ 1797624971810308096
author Samaneh Delavari
Yating Wang
Tannaz Moeini shad
Salar Pashangzadeh
Farzad Nazari
Fereshte Salami
Hassan Abolhassani
author_facet Samaneh Delavari
Yating Wang
Tannaz Moeini shad
Salar Pashangzadeh
Farzad Nazari
Fereshte Salami
Hassan Abolhassani
author_sort Samaneh Delavari
collection DOAJ
description Inborn errors of immunity (IEI) are a heterogeneous group of inherited disorders, and almost 500 genes associated with these disorders have been identified. Defects in IEI genes lead to diverse clinical manifestations including increased susceptibility to recurrent or prolonged infections, immune dysregulation phenotypes (such as severe atopy, allergy, autoimmunity, and uncontrolled inflammation, lymphoproliferation), as well as predisposition to malignancies. Although the majority of IEI patients present hematologic cancers, the characteristics of other types of cancers are not well described in these groups of patients. By investigating 5384 IEI patients registered in the Iranian national registry the clinical and immunologic phenotypes of patients with non-hematologic cancers were compared with other malignant and non-malignant patients. Solid tumors were reported <20% of malignant IEI patients (<i>n</i> = 27/144 patients) and appeared to be very heterogeneous by type and localization as well as molecular defects (mainly due to DNA repair defect resulted from ATM deficiency). The correlation between the type of malignancy and survival status was remarkable as patients with non-hematologic cancers survive higher than IEI patients with hematologic cancers. Our findings showed that different types of malignancy could be associated with specific entities of IEI. Therefore, the education of physicians about the risk of malignancies in IEI is required for personalized treatment and appropriate management of patients.
first_indexed 2024-03-11T09:50:13Z
format Article
id doaj.art-8e169c95097345a9890457a11f20b901
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-11T09:50:13Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-8e169c95097345a9890457a11f20b9012023-11-16T16:16:51ZengMDPI AGCancers2072-66942023-01-0115376410.3390/cancers15030764Clinical and Immunologic Characteristics of Non-Hematologic Cancers in Patients with Inborn Errors of ImmunitySamaneh Delavari0Yating Wang1Tannaz Moeini shad2Salar Pashangzadeh3Farzad Nazari4Fereshte Salami5Hassan Abolhassani6Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Science, 1419733151 Tehran, IranDivision of Clinical Immunology, Department of Biosciences and Nutrition, Karolinska Institute, 14183 Stockholm, SwedenResearch Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Science, 1419733151 Tehran, IranResearch Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Science, 1419733151 Tehran, IranResearch Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Science, 1419733151 Tehran, IranResearch Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Science, 1419733151 Tehran, IranResearch Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Science, 1419733151 Tehran, IranInborn errors of immunity (IEI) are a heterogeneous group of inherited disorders, and almost 500 genes associated with these disorders have been identified. Defects in IEI genes lead to diverse clinical manifestations including increased susceptibility to recurrent or prolonged infections, immune dysregulation phenotypes (such as severe atopy, allergy, autoimmunity, and uncontrolled inflammation, lymphoproliferation), as well as predisposition to malignancies. Although the majority of IEI patients present hematologic cancers, the characteristics of other types of cancers are not well described in these groups of patients. By investigating 5384 IEI patients registered in the Iranian national registry the clinical and immunologic phenotypes of patients with non-hematologic cancers were compared with other malignant and non-malignant patients. Solid tumors were reported <20% of malignant IEI patients (<i>n</i> = 27/144 patients) and appeared to be very heterogeneous by type and localization as well as molecular defects (mainly due to DNA repair defect resulted from ATM deficiency). The correlation between the type of malignancy and survival status was remarkable as patients with non-hematologic cancers survive higher than IEI patients with hematologic cancers. Our findings showed that different types of malignancy could be associated with specific entities of IEI. Therefore, the education of physicians about the risk of malignancies in IEI is required for personalized treatment and appropriate management of patients.https://www.mdpi.com/2072-6694/15/3/764inborn errors of immunityprimary immunodeficiencymalignancysolid tumors
spellingShingle Samaneh Delavari
Yating Wang
Tannaz Moeini shad
Salar Pashangzadeh
Farzad Nazari
Fereshte Salami
Hassan Abolhassani
Clinical and Immunologic Characteristics of Non-Hematologic Cancers in Patients with Inborn Errors of Immunity
Cancers
inborn errors of immunity
primary immunodeficiency
malignancy
solid tumors
title Clinical and Immunologic Characteristics of Non-Hematologic Cancers in Patients with Inborn Errors of Immunity
title_full Clinical and Immunologic Characteristics of Non-Hematologic Cancers in Patients with Inborn Errors of Immunity
title_fullStr Clinical and Immunologic Characteristics of Non-Hematologic Cancers in Patients with Inborn Errors of Immunity
title_full_unstemmed Clinical and Immunologic Characteristics of Non-Hematologic Cancers in Patients with Inborn Errors of Immunity
title_short Clinical and Immunologic Characteristics of Non-Hematologic Cancers in Patients with Inborn Errors of Immunity
title_sort clinical and immunologic characteristics of non hematologic cancers in patients with inborn errors of immunity
topic inborn errors of immunity
primary immunodeficiency
malignancy
solid tumors
url https://www.mdpi.com/2072-6694/15/3/764
work_keys_str_mv AT samanehdelavari clinicalandimmunologiccharacteristicsofnonhematologiccancersinpatientswithinbornerrorsofimmunity
AT yatingwang clinicalandimmunologiccharacteristicsofnonhematologiccancersinpatientswithinbornerrorsofimmunity
AT tannazmoeinishad clinicalandimmunologiccharacteristicsofnonhematologiccancersinpatientswithinbornerrorsofimmunity
AT salarpashangzadeh clinicalandimmunologiccharacteristicsofnonhematologiccancersinpatientswithinbornerrorsofimmunity
AT farzadnazari clinicalandimmunologiccharacteristicsofnonhematologiccancersinpatientswithinbornerrorsofimmunity
AT fereshtesalami clinicalandimmunologiccharacteristicsofnonhematologiccancersinpatientswithinbornerrorsofimmunity
AT hassanabolhassani clinicalandimmunologiccharacteristicsofnonhematologiccancersinpatientswithinbornerrorsofimmunity